Krystal Biotech, Inc. (KRYS) Total liabilities 2021–2025
Krystal Biotech, Inc. (KRYS) total liabilities at each fiscal year-end, per SEC filings.
$114.2MFY2025 · since FY2021: $32.7M → $114.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $114.2M | +4.4% |
| FY2024 | $109.5M | +175.6% |
| FY2023 | $39.7M | +9.6% |
| FY2022 | $36.2M | +10.7% |
| FY2021 | $32.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice